SALES AGREEMENTSales Agreement • June 28th, 2016 • Aethlon Medical Inc • Laboratory analytical instruments • New York
CONSENT AND WAIVERConsent and Waiver • June 28th, 2016 • Aethlon Medical Inc • Laboratory analytical instruments
This CONSENT AND WAIVER is entered into as of June __, 2016, by and between Aethlon Medical, Inc., a Nevada corporation (the “Company”) and the undersigned investor (the “Investor”), which is one of several investors set forth on the signature pages affixed to that certain Securities Purchase Agreement between the Company and the Investors, dated June 23, 2015, as amended (the “SPA”; all capitalized terms used and not defined herein are used as defined in the SPA).
ALLONGE TO CONVERTIBLE PROMISSORY NOTEConvertible Promissory Note • June 28th, 2016 • Aethlon Medical Inc • Laboratory analytical instruments
Allonge to that certain Convertible Promissory Note attached hereto as Exhibit 1 and made a part hereof in the original principal amount of $_____________ dated November 6, 2014 (“Note”), from Aethlon Medical, Inc., as Borrower, to the order of _____________, as Lender ("Allonge").
CONSENT AND WAIVER AND AMENDMENTConsent and Waiver and Amendment • June 28th, 2016 • Aethlon Medical Inc • Laboratory analytical instruments
This CONSENT AND WAIVER AND AMENDMENT is entered into as of June __, 2016, by and between Aethlon Medical, Inc., a Nevada corporation (the “Company”) and the undersigned investor (the “Investor”), which is one of several investors set forth on the signature pages affixed to that certain Securities Purchase Agreement between the Company and the Investors, dated November 26, 2014, as amended (the “SPA”; all capitalized terms used and not defined herein are used as defined in the SPA).
AMENDMENTSubscription Agreement • June 28th, 2016 • Aethlon Medical Inc • Laboratory analytical instruments
This Amendment (“Amendment”) is entered into as of June ___, 2016, by and between Aethlon, Inc., a Nevada corporation (the “Company”), and the undersigned Subscriber (the “Subscriber”), which is one of the investors listed on the Schedule of Subscribers (“Schedule of Subscribers”) attached to that certain Subscription Agreement between the Company and the investors listed on the Schedule of Subscribers (the “Subscribers”) dated November 6, 2014, as amended (the “SA”; all capitalized terms used and not defined herein are used as defined in the Notes, as amended (as defined in the SA)) with reference to the following facts:
